You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API CARBAMAZEPINE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing CARBAMAZEPINE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Novartis Pharmaceuticals Corporation TEGRETOL carbamazepine 0078-0508 CITRIC ACID MONOHYDRATE
Novartis Pharmaceuticals Corporation TEGRETOL carbamazepine 0078-0508 FD&C YELLOW NO. 6
Novartis Pharmaceuticals Corporation TEGRETOL carbamazepine 0078-0508 POTASSIUM SORBATE
Novartis Pharmaceuticals Corporation TEGRETOL carbamazepine 0078-0508 PROPYLENE GLYCOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for CARBAMAZEPINE

Excipient focus: ACACIA

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: AMMONIO METHACRYLATE COPOLYMER TYPE A

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: BROWN IRON OXIDE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CELLULOSE ACETATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: D&C YELLOW NO. 10

Excipient focus: DEXTRATES

Excipient focus: DIETHYL PHTHALATE

Excipient focus: ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER

Excipient focus: ETHYLCELLULOSE

Excipient focus: ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A

Excipient focus: ETHYLCELLULOSES

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROXYETHYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: OLEIC ACID

Excipient focus: POLOXAMER 188

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POTASSIUM SORBATE

Excipient focus: POVIDONE

Excipient focus: POWDERED CELLULOSE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURETH SULFATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SORBITOL

Excipient focus: SORBITOL SOLUTION

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: SUCROSE

Excipient focus: SULFOBUTYLETHER .BETA.-CYCLODEXTRIN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIETHYL CITRATE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: VANILLIN

Excipient focus: WATER

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group